£425.00

It has never been this cheap. We have no record of a lower price.

£425 today · cheaper than every other day in the last 3 months

The 2016-2021 Outlook for Anti-Migraine Drugs in North America & the Caribbean

View at Amazon

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 26 days · 26 data points (no recent data)

Historical
Generating forecast…
£425.00 £403.75 £412.25 £420.75 £429.25 £437.75 £446.25 26 July 2026 01 August 2026 07 August 2026 13 August 2026 20 August 2026
View at Amazon ↗

Price data last checked 65 day(s) ago - refreshing...

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↑ Price chart
when this has been cheap or pricey
↑ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price Distribution

Price distribution over 26 days • 1 price levels

Days at Price
26 days 0 7 13 20 26 £425 Days at Price

Price Analysis

Most common price: £425 (26 days, 100.0%)

Price range: £425 - £425

Price levels: 1 different prices over 26 days

Description
This econometric study covers the outlook for anti-migraine drugs in North America & the Caribbean. For each year reported, estimates are given for the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow the reader to quickly gauge a country vis-a-vis others. Using econometric models which project fundamental economic dynamics within each country and across countries, latent demand estimates are created. This report does not discuss the specific players in the market serving the latent demand, nor specific details at the product level. The study also does not consider short-term cyclicalities that might affect realized sales. The study, therefore, is strategic in nature, taking an aggregate and long-run view, irrespective of the players or products involved. This study does not report actual sales data (which are simply unavailable, in a comparable or consistent manner in virtually all of the countries in North America & the Caribbean). This study gives, however, my estimates for the latent demand, or the P.I.E. for anti-migraine drugs in North America & the Caribbean. It also shows how the P.I.E. is divided across the national markets of North America & the Caribbean. For each country, I also show my estimates of how the P.I.E. grows over time (positive or negative growth). In order to make these estimates, a multi-stage methodology was employed that is often taught in courses on international strategic planning at graduate schools of business.

Product Specifications
Format
paperback
ASIN
B0161TEZP4
Category
Books > Subjects > Business, Finance & Law > Economics > Econometrics
Domain
Amazon UK
Release Date
21 May 2015
Listed Since
01 October 2015

Similar Products You Might Like

The 2016-2021 Outlook for Anti-Migraine Drugs in Latin America
99% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Latin America

£425.00 22 Aug 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Europe
99% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Europe

£425.00 24 Aug 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Asia
99% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Asia

£425.00 21 Aug 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Africa & the Middle East
99% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Africa & the Middle East

£425.00 20 Aug 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Oceana
99% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Oceana

£425.00 26 Sep 2026
The 2013-2018 Outlook for Anti-Migraine Drugs in Europe & the Middle East
99% match

The 2013-2018 Outlook for Anti-Migraine Drugs in Europe & the Middle East

£325.00 19 Aug 2026
The 2011-2016 Outlook for Anti-Migraine Drugs in The Middle East
99% match

The 2011-2016 Outlook for Anti-Migraine Drugs in The Middle East

£325.00 24 Aug 2026
The 2021-2026 World Outlook for Anti-Migraine Drugs
99% match

The 2021-2026 World Outlook for Anti-Migraine Drugs

£795.00 24 Aug 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in the United States
99% match

The 2016-2021 Outlook for Anti-Migraine Drugs in the United States

£595.00 21 Aug 2026
The 2023-2028 Outlook for Anti-Migraine Drugs in the United States
99% match

The 2023-2028 Outlook for Anti-Migraine Drugs in the United States

£520.00 22 Aug 2026
The 2016-2021 Outlook for Anti-Migraine Drugs in Greater China
99% match

The 2016-2021 Outlook for Anti-Migraine Drugs in Greater China

£595.00 25 Aug 2026
The 2023-2028 Outlook for Anti-Migraine Drugs in India
98% match

The 2023-2028 Outlook for Anti-Migraine Drugs in India

£515.00 24 Aug 2026
The 2025-2030 World Outlook for Anti-Migraine Drugs
98% match

The 2025-2030 World Outlook for Anti-Migraine Drugs

Price unavailable
The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs
98% match

The 2023-2028 World Outlook for Acute-Treatment Migraine Drugs

£795.00 22 Aug 2026
The 2023-2028 Outlook for Anti-Migraine Drugs for US Zip Codes
98% match

The 2023-2028 Outlook for Anti-Migraine Drugs for US Zip Codes

£490.00 04 Sep 2026
Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)
97% match

Traitements de crise et traitements de fond de la migraine: Aspects pharmacothérapeutiques (Omn.Univ.Europ.)

OmniScriptum

£70.00 30 Sep 2026
Management of Migraine Pain: Emerging Opportunities and Challenges
97% match

Management of Migraine Pain: Emerging Opportunities and Challenges

Springer

£162.90 02 Oct 2026
Migraine and Headache Disorders: Global Perspective - SDG3
97% match

Migraine and Headache Disorders: Global Perspective - SDG3

Springer

£95.74 25 Sep 2026
Interventional Management of Migraines and Headache Disorders Book
97% match

Interventional Management of Migraines and Headache Disorders Book

Elsevier

£119.49 02 Oct 2026
Migraine, Words and Fiction
96% match

Migraine, Words and Fiction

Cambridge Scholars Publishing

£67.99 23 Sep 2026
Migraine
96% match

Migraine

IntechOpen

£118.98 12 Sep 2026
The Biochemistry of Migraine
96% match

The Biochemistry of Migraine

Springer

£158.11 19 Sep 2026
Comorbid Conditions in the Treatment of Headache
96% match

Comorbid Conditions in the Treatment of Headache

CRC Press

£75.11 11 Sep 2026
Clinical Scales for Headache Disorders
96% match

Clinical Scales for Headache Disorders

Springer

£95.74 19 Sep 2026